State Street’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$17M Sell
9,890,525
-1,150,797
-10% -$1.98M ﹤0.01% 2275
2025
Q1
$36.8M Sell
11,041,322
-1,207,960
-10% -$4.02M ﹤0.01% 1808
2024
Q4
$90.6M Sell
12,249,282
-952,696
-7% -$7.05M ﹤0.01% 1403
2024
Q3
$124M Buy
13,201,978
+576,801
+5% +$5.42M 0.01% 1206
2024
Q2
$101M Buy
12,625,177
+2,222,458
+21% +$17.8M ﹤0.01% 1249
2024
Q1
$154M Sell
10,402,719
-6,021,669
-37% -$89.2M 0.01% 1032
2023
Q4
$134M Sell
16,424,388
-307,881
-2% -$2.5M 0.01% 1103
2023
Q3
$76.1M Buy
16,732,269
+3,166,471
+23% +$14.4M ﹤0.01% 1357
2023
Q2
$95.5M Sell
13,565,798
-167,235
-1% -$1.18M 0.01% 1253
2023
Q1
$83.9M Sell
13,733,033
-982,442
-7% -$6M ﹤0.01% 1304
2022
Q4
$94M Buy
14,715,475
+4,783,323
+48% +$30.6M 0.01% 1192
2022
Q3
$95.2M Sell
9,932,152
-1,838,599
-16% -$17.6M 0.01% 1130
2022
Q2
$130M Buy
11,770,751
+4,925,025
+72% +$54.4M 0.01% 996
2022
Q1
$114M Buy
6,845,726
+1,752,044
+34% +$29.2M 0.01% 1199
2021
Q4
$97.2M Buy
5,093,682
+705,576
+16% +$13.5M ﹤0.01% 1320
2021
Q3
$108M Buy
4,388,106
+445,433
+11% +$11M 0.01% 1193
2021
Q2
$103M Buy
3,942,673
+867,022
+28% +$22.6M 0.01% 1267
2021
Q1
$97.4M Buy
3,075,651
+178,572
+6% +$5.65M 0.01% 1254
2020
Q4
$134M Sell
2,897,079
-272,482
-9% -$12.6M 0.01% 941
2020
Q3
$104M Sell
3,169,561
-233,112
-7% -$7.67M 0.01% 948
2020
Q2
$93.4M Sell
3,402,673
-995,498
-23% -$27.3M 0.01% 1008
2020
Q1
$132M Buy
4,398,171
+73,995
+2% +$2.22M 0.01% 732
2019
Q4
$120M Sell
4,324,176
-434,043
-9% -$12M 0.01% 933
2019
Q3
$86.6M Buy
4,758,219
+1,336,353
+39% +$24.3M 0.01% 1090
2019
Q2
$83.9M Sell
3,421,866
-641,369
-16% -$15.7M 0.01% 1166
2019
Q1
$38.6M Sell
4,063,235
-416,017
-9% -$3.96M ﹤0.01% 1603
2018
Q4
$39.6M Buy
4,479,252
+496,690
+12% +$4.4M ﹤0.01% 1500
2018
Q3
$44.8M Buy
3,982,562
+127,418
+3% +$1.43M ﹤0.01% 1606
2018
Q2
$49.4M Buy
3,855,144
+1,652,863
+75% +$21.2M ﹤0.01% 1502
2018
Q1
$37.2M Buy
2,202,281
+291,769
+15% +$4.93M ﹤0.01% 1613
2017
Q4
$15.3M Buy
1,910,512
+894,958
+88% +$7.16M ﹤0.01% 2233
2017
Q3
$7.87M Buy
1,015,554
+24,163
+2% +$187K ﹤0.01% 2554
2017
Q2
$7.29M Buy
991,391
+66,560
+7% +$489K ﹤0.01% 2549
2017
Q1
$6.89M Buy
924,831
+61,248
+7% +$456K ﹤0.01% 2548
2016
Q4
$6M Buy
863,583
+143,220
+20% +$996K ﹤0.01% 2586
2016
Q3
$5.93M Buy
720,363
+27,579
+4% +$227K ﹤0.01% 2466
2016
Q2
$5.61M Buy
692,784
+22,681
+3% +$184K ﹤0.01% 2525
2016
Q1
$3.41M Buy
670,103
+1,206
+0.2% +$6.13K ﹤0.01% 2751
2015
Q4
$5.16M Buy
668,897
+86,672
+15% +$669K ﹤0.01% 2519
2015
Q3
$3.36M Buy
582,225
+110,736
+23% +$638K ﹤0.01% 2735
2015
Q2
$4.33M Buy
+471,489
New +$4.33M ﹤0.01% 2699